Less understood issues: p21Cip1 in mitosis and its therapeutic potential

被引:95
作者
Kreis, N-N [1 ]
Louwen, F. [1 ]
Yuan, J. [1 ]
机构
[1] Goethe Univ Frankfurt, Dept Gynecol & Obstet, D-60590 Frankfurt, Germany
关键词
CELL-CYCLE INHIBITORS; DNA-REPLICATION; UBIQUITIN LIGASE; CDK INHIBITOR; CYTOPLASMIC LOCALIZATION; PROTEASOMAL DEGRADATION; DEPENDENT KINASES; NUCLEAR ANTIGEN; BREAST-CANCER; S-PHASE;
D O I
10.1038/onc.2014.133
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p21(Cip1) is a multifunctional protein and a key player in regulating different cellular processes. The transcription of p21 is regulated by p53-dependent and -independent pathways. The expression of p21 is increased in response to various cellular stresses to arrest the cell cycle and ensure genomic stability. p21 has been shown to be a tumor suppressor and an oncogene as well. The function of p21 in mitosis has been proposed but not systematically studied. We have recently shown that p21 binds to and inhibits the activity of Cdk1/cyclin B1, and is important for a fine-tuned mitotic progression. Loss of p21 prolongs the duration of mitosis and results in severe mitotic defects like chromosome segregation and cytokinesis failures promoting consequently genomic instability. Moreover, p21 is dramatically stabilized in mitotic tumor cells upon treatment with mitotic agents like paclitaxel or mitotic kinase inhibitors. Increased p21 is mainly localized in the cytoplasm and associates with cell survival indicating a crucial role of p21 in susceptibility to mitotic agents in tumor cells. In this review we will briefly summarize the structure and general physiological functions as well as regulation of p21, discuss in detail its role in mitosis and its potential to serve as a therapeutic target.
引用
收藏
页码:1758 / 1767
页数:10
相关论文
共 179 条
[1]   PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex [J].
Abbas, Tarek ;
Sivaprasad, Uma ;
Terai, Kenta ;
Amador, Virginia ;
Pagano, Michele ;
Dutta, Anindya .
GENES & DEVELOPMENT, 2008, 22 (18) :2496-2506
[2]   p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[3]  
Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744
[4]   The diverging roles of calmodulin and PKC in the regulation of p21 intracellular localization [J].
Agell, N ;
Jaumot, M ;
Rodríguez-Vilarrupla, A ;
Brun, S ;
Abella, N ;
Canela, N ;
Estanyol, JM .
CELL CYCLE, 2006, 5 (01) :3-6
[5]   APC/CCdc20 controls the ubiquitin-mediated degradation of p21 in prometaphase [J].
Amador, Virginia ;
Ge, Sheng ;
Santamaria, Patricia G. ;
Guardavaccaro, Daniele ;
Pagano, Michele .
MOLECULAR CELL, 2007, 27 (03) :462-473
[6]   Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage [J].
Ando, T ;
Kawabe, T ;
Ohara, H ;
Ducommun, B ;
Itoh, M ;
Okamoto, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) :42971-42977
[7]   p21 delays tumor onset by preservation of chromosomal [J].
Barboza, Juan A. ;
Liu, Geng ;
Ju, Zhenlin ;
El-Naggar, Adel K. ;
Lozano, Guillermina .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (52) :19842-19847
[8]   Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression [J].
Bates, S ;
Ryan, KM ;
Phillips, AC ;
Vousden, KH .
ONCOGENE, 1998, 17 (13) :1691-1703
[9]   Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts [J].
Baus, F ;
Gire, V ;
Fisher, D ;
Piette, J ;
Dulic, V .
EMBO JOURNAL, 2003, 22 (15) :3992-4002
[10]   CDK inhibitors: Cell cycle regulators and beyond [J].
Besson, Arnaud ;
Dowdy, Steven F. ;
Roberts, James M. .
DEVELOPMENTAL CELL, 2008, 14 (02) :159-169